Peripheral axons from auditory spiral ganglion neurons (SGNs) form an elaborate series of radially and spirally oriented projections that interpret complex aspects of the auditory environment. However, the developmental processes that shape these axon tracts are largely unknown. Radial bundles are comprised of dense SGN fascicles that project through otic mesenchyme to form synapses within the cochlea. Here, we show that radial bundle fasciculation and synapse formation are disrupted when Pou3f4 (DFNX2) is deleted from otic mesenchyme. Further, we demonstrate that Pou3f4 binds to and directly regulates expression of Epha4, Epha4 À/À mice present similar SGN defects, and exogenous EphA4 promotes SGN fasciculation in the absence of Pou3f4. Finally, Efnb2 deletion in SGNs leads to similar fasciculation defects, suggesting that ephrin-B2/EphA4 interactions are critical during this process. These results indicate a model whereby Pou3f4 in the otic mesenchyme establishes an Eph/ ephrin-mediated fasciculation signal that promotes inner radial bundle formation.
INTRODUCTION
Hearing depends on hair-cell-mediated conversion of sound stimuli into electrochemical information that is then relayed to the brain via spiral ganglion neurons (SGNs), a cluster of bipolar afferent neurons that parallel the medial surface of the cochlear coil. Although considerable research has been conducted on the patterning of the hair cells and support cells within the cochlea (Driver and Kelley, 2009; Kelley, 2006; Puligilla and Kelley, 2009) , relatively little work has focused on mechanisms that control the patterning, migration, and outgrowth of the SGNs (reviewed in Appler and Goodrich, 2011) . As essential regulators of auditory information, a better understanding of how these processes occur within SGNs will enhance our understanding of auditory function, as well as how neural connections might be reformed in cases of deafness.
During development, immature proliferating neuroblasts delaminate from the otocyst (Ruben, 1967) and migrate to form a dense ganglion along the medial side of the inner ear epithelium. As development continues, developing SGNs extend peripheral axons through the surrounding (otic) mesenchyme cells (Carney and Silver, 1983) and subsequently penetrate the cochlear epithelium to form glutamate-responsive ribbon-type synapses with inner and outer hair cells (Smith, 1961) . During this process, SGN axons form a series of dense fascicles, referred to as inner radial bundles, each of which contains fibers with similar frequency tuning. Groundbreaking work has begun to delineate the regulatory networks that establish the circuitry between the cochlea and the central nervous system (CNS) ; however, specific mechanisms regulating SGN developmental patterning are unknown.
The POU-domain (Pit1-Oct1/2-unc86) proteins are a phylogenetically conserved family of transcription factors with diverse DNA-binding affinities and a wide range of developmental functions (Phillips and Luisi, 2000; Ryan and Rosenfeld, 1997) . Mutations in POU3F4/Pou3f4, located on the X chromosome, cause deafness in humans (DFNX2) and mice (Kandpal et al., 1996; Minowa et al., 1999) . Expression studies indicate that Pou3f4 expression is restricted to otic mesenchyme cells, with limited or no expression in the hair cells or SGNs (Minowa et al., 1999; Phippard et al., 1998; Samadi et al., 2005) . Consistent with this, the cochlear sensory epithelium (organ of Corti), which includes hair cells and supporting cells, appears normal in Pou3f4 À/À mice. However, the cochlear duct has been described as dysplastic with a moderate length reduction, possibly owing to disorganization and altered morphology of otic mesenchyme cells (Minowa et al., 1999; Phippard et al., 1999) . Considering the intimate relationship between developing SGNs and otic mesenchyme, defects in aspects of SGN formation in the absence of Pou3f4 seemed possible. Any effects of Pou3f4 on SGN formation would most likely be indirect and therefore mediated by other factors. In particular, Eph receptors, the largest family of vertebrate receptor tyrosine kinases, are known to interact with ephrin ligands to generate both forward and reverse signals and have been linked extensively with axon guidance (Coate et al., 2009; Huai and Drescher, 2001; Pasquale, 2005; Wilkinson, 2001) . Although several studies have documented the presence of Ephs and ephrins in the inner ear (Bianchi and Gale, 1998; Zhou et al., 2011) , a role for fasciculation and/or radial bundle formation has not been described.
RESULTS

Pou3f4 Is Expressed by Otic Mesenchyme Cells during All Stages of SGN Development
Pou3f4 expression in the otic mesenchyme has been described previously (Ahn et al., 2009; Phippard et al., 1998) , but those studies did not determine whether other cells nearby, such as SGNs or associated glia, were also positive for Pou3f4. Thus, we conducted a comprehensive temporal and spatial analysis of Pou3f4 protein expression during SGN development using a Pou3f4-specific antibody, along with markers of mature auditory neurons (Tuj1) and Schwann cells (Sox10; Puligilla et al., 2010) . In mice, SGNs develop within the cochleovestibular ganglion (cvg), a transient structure formed by neuroblasts that delaminate from the ventral-medial side of the otocyst at embryonic day (E) 9.5 ( Figures 1A and 1B) . At E9.5, Pou3f4 expression in the presumptive mesenchyme is not detectable ( Figure 1A) ; however, at E10.5, small patches of Pou3f4-expressing mesenchyme cells emerge adjacent to the cvg ( Figure 1B, see arrows) . By E12.5, when the auditory and vestibular components of the inner ear have diverged , Pou3f4 is detectable in all compartments of the otic mesenchyme ( Figure 1C ). At this stage, neural crest-derived Schwann cells infiltrate the ganglia, and SGNs begin to project peripheral axons toward the prosensory domain located within the cochlear epithelium (Carney and Silver, 1983) . At these early stages, Pou3f4 is detectable in otic mesenchyme cells, but not in neurons, glia, or epithelia. Moreover, Pou3f4-expressing mesenchyme cells appear to make direct contact with the distal ends of the SGN peripheral axons (Figure 1C, arrowheads) in regions where Schwann cells have not yet arrived. At E16.5, SGN peripheral axon outgrowth continues along the length of the cochlea as the otic mesenchyme (om) population expands to form the future osseous spiral lamina and spiral limbus (osl and sl, respectively; Figures 1D and 1E ). The adult osl consists of bony plates that surround the SGN axons, and the sl is a thickened periosteum. At E15.5-E16.5, radial bundles form concurrently with the appearance of bands of mesenchyme cells located between SGN peripheral axons (as in Figure 2G , asterisks). By P2, Pou3f4-positive mesenchyme cells segregate from extending SGN axons, with clearly visible boundaries ( Figure 1E ). Occasional Pou3f4-positive cells were observed within the somal layer of the spiral ganglion ( Figure 1E ), but these cells were not positive for either Tuj1 or Sox10, suggesting that they are mesenchyme cells that have interspersed the ganglion during development (arrows in Figures 1E and 1F ). In whole mount at E17.5, the segregation of the peripheral axons and the otic mesenchyme is dramatic: groups of $50-100 axons fasciculate to form relatively evenly spaced inner radial bundles along the length of the cochlea ( Figures 1G-1I ). Higher-magnification images show how axons travel in areas that are devoid of Pou3f4 and rarely cross between bundles ( Figures 1J-1O) . . Arrows point to defasciculated axons. The black arrow (with white stroke) points to the intraganglionic spiral axon bundle (Simmons et al., 2011 ) that also shows fasciculation defects. (Minowa et al., 1999; Phippard et al., 1999) . Therefore, we hypothesized that if SGN fasciculation and otic mesenchyme organization are interdependent, then inner radial bundle formation may require Pou3f4. To test this hypothesis, we compared radial bundle development in whole-mount preparations of Pou3f4 y/+ and Pou3f4 y/À cochleae (Figures 2A-2H ). At E17.5,
Pou3f4
y/+ cochleae contained dense, well-organized fascicles that projected directly from the SGN soma to the cochlear epithelium (Figures 2A-2C ). This pattern is most conspicuous at the base of the cochlea (Figures 2A and 2B ) but is also evident at the apex ( Figure 2C ), where the bundles are always less compact. In contrast, SGN axons in Pou3f4 y/À embryos failed to fasciculate properly, formed loosely compacted bundles, and contained increased numbers of laterally projecting processes ( Figures  2D-2F ). Although this fasciculation phenotype could arise from a deficit of auditory glia (Breuskin et al., 2010) , there appeared to be no defect in their development ( Figure 2E ; Sox10 staining). Fasciculation defects were evident in Pou3f4 y/À embryos as early as E15.5 ( Figures 2G and 2H ), suggesting disruptions during the early phases of axon outgrowth.
To quantify fasciculation along the length of the cochlea, we measured the total area occupied by SGN axons between the soma and the sensory epithelium (see Experimental Procedures; Figures 2I and 2J ). In base, middle, and apical regions of the cochlea, the SGN axons in Pou3f4 y/À embryos consumed significantly more space compared to their wild-type littermates ( Figure 2K ), with the greatest difference in fasciculation present at the apex (80% versus 91%, respectively; see Figure 2K , light gray bars). In addition, the frequency with which processes crossed between fascicles was significantly greater in Pou3f4 y/À embryos compared to wild-type ( Figure 2L ; arrows in Figure 2D ). Pou3f4 y/À cochleae have been reported to be slightly shorter than controls, which raised the possibility that the SGN fasciculation defects might result from changes in neuron numbers along the length of the cochlea. However, a comparison of the density of SGN cell bodies between Pou3f4 y/+ and Pou3f4 y/À cochleae indicated no significant differences ( Figure 2M ; see also Figure S1 available online).
To determine whether a loss of surrounding otic mesenchyme cells caused the SGN fasciculation defects in Pou3f4 y/À mice, we compared the frequency of apoptotic cells in the otic mesenchyme between Pou3f4 y/+ and Pou3f4 y/À animals using antibodies against cleaved caspase-3 (CC3) (Figures S1E-S1J). We also used DAPI to look for potential necrotic lesions ( Figures S1L-S1O ).
Although the density of the mesenchyme cells appeared to be slightly lower in Pou3f4 y/À animals (compare the outlined areas in
Figures S1G and S1J), there was no enhanced apoptosis or necrosis in the otic mesenchyme cells ( Figures S1K-S1O ).
Innervation and Ribbon Synapse Formation Are Diminished in Pou3f4 y/-Embryos Axon fasciculation reduces pathfinding errors and provides efficient innervation of target tissues (Tessier-Lavigne and Goodman, 1996) . Considering the fasciculation defects in the Pou3f4 y/À cochleae, we examined possible changes in innervation. SGNs are subdivided into two classes: type I SGNs (90% of the entire population), which form synapses on inner hair cells, and type II SGNs (the remaining 10%), which grow past the inner hair cell layer, cross the tunnel of Corti, and then turn toward the base before forming synapses with outer hair cells (Huang et al., 2007; Koundakjian et al., 2007) . At the base of wild-type cochleae at E17.5, Tuj-l immunolabeling shows the dense layer of type I SGN endings, as well as type II processes that cross the pillar cell layer before turning toward the base ( Figure 3A ). These preparations were counterstained with Sox10 antibodies to reveal the morphology of the cochlear epithelium with respect to the SGNs ( Figures 3B and 3C ). Images acquired at the midbase, midapex, and apex ( Figures 2D-2F 3L ). In addition, the type II processes that were present appeared to be shorter and less mature (Figures 3J and 3K) or had not extended ( Figure 3L ). Sox10 immunostaining indicated no changes in the morphology of the supporting cells in Pou3f4 y/À cochleae ( Figures 3H and 3I ).
These data suggest that fasciculation defects result in diminished target innervation within the cochlear epithelium. We therefore reasoned that synapse numbers between SGNs and hair cells would also be reduced in Pou3f4 y/À mice. In hair cells, $500 nm ribbon-type synapses can be visualized and quantified using anti-Ribeye antibodies (Meyer et al., 2009; Figures 3M-3P) . Postsynaptic glutamate receptor immunoreactivity has a diffuse appearance at early postnatal stages but is suitable for qualitative observations (Nemzou N et al., 2006; Figures 3M-3P) . Comparisons at postnatal day eight (P8) indicated fewer ribbon synapses and lower levels of glutamate receptor immunoreactivity in Pou3f4 y/À mice ( Figures 3M-3P ).
Cross-sections of cochleae at P8, immunostained with neurofilament and Ribeye antibodies, confirmed a decrease in the density of type I SGN endings and showed a quantifiable decrease in the number of ribbon synapses . Consistent with the gradient in innervation defects, the decrease in ribbon synapses was also graded with a mild effect in the base of the cochlea and a more severe effect at the apex (reduced by approximately 30%). These data suggest that disrupting fasciculation impairs the ability of SGNs to locate their targets and form synapses.
Expression of EphA4 Is Reduced in Otic Mesenchyme Lacking Pou3f4
Fasciculation is typically mediated by cell-surface or secreted factors (Tessier-Lavigne and Goodman, 1996) (Gallarda et al., 2008) , and axon fasciculation (Bossing and Brand, 2002; Orioli et al., 1996) . Therefore, the developmental expression pattern of EphA4 in the cochlea was examined ( Figures 4A-4F ). Through the use of in situ hybridization, we found that Epha4 mRNA is broadly distributed at E14.5 (data not shown) and E16.5 (Figures 4A and 4B), localizing to mesenchyme, the spiral ganglion, and the cochlear epithelium. However, we saw a remarkably limited pattern of expression with antibodies specific to the extracellular domain of EphA4 protein: virtually all immunoreactivity was This antibody also recognizes CtBp2 (n in all hair cell nuclei). IHC, inner hair cell. Anti-GluR2/3 in (N) indicates postsynaptic glutamate receptors. Immunostaining for both factors in the mutant appears reduced (arrowheads). Scale bar in (P) represents 8 mm.
(Q and R) Midmodiolar cross-sections of the inner hair cell region from Pou3f4 y/+ (Q) and Pou3f4 y/À (R) cochleae at E17.5. Nerve terminals are marked by antineurofilament (200 kDa). Note the decreased density of nerve fibers contacting the inner hair cell in Pou3f4 y/À (arrowheads). Scale bar in (R) represents 5 mm.
(S and T) A high-magnification view of the synaptic region from the inner hair cell in (Q). Punctate spots (circled in T) represent individual ribbon synapses.
(U and W) Similar view as in (S) and (T) but from the Pou3f4 y/À inner hair cell in (R). Note the decreased number of ribbon puncta. Scale bar represents 4 mm.
(X) Histogram indicating a significant decrease in the number of inner hair cell synapses (mean ± SEM) in Pou3f4 y/À cochleae at P8. **p % 0.01; ***p % 0.001. preparations and orthogonal reconstructions of E18.5 cochleae show that EphA4 is distributed in the Pou3f4-positive mesenchyme bands between the SGN fascicles but does not overlap with Tuj1 ( Figures 4I-4N ). These results indicate that EphA4 protein is distributed in a spatial and temporal manner consistent with a role in SGN fasciculation. It is unclear why there is a discrepancy between EphA4 mRNA and protein distribution, but a posttranscriptional regulatory program that limits EphA4 protein to the mesenchyme may be present.
To confirm that EphA4 expression in the mesenchyme depends on Pou3f4, we used quantitative PCR to show an approximate 5-fold reduction in Epha4 expression in Pou3f4 y/À cochleae ( Figure 4O ). Moreover, analyses of whole-mount preparations from Pou3f4 y/À cochleae show that EphA4 protein is substantially reduced in the otic mesenchyme at E17.5 ( Figures  4P-4U ).
EphA4 Promotes SGN Fasciculation and Hair Cell Innervation
If Pou3f4 transcriptional activity regulates Epha4 expression in the otic mesenchyme to promote SGN fasciculation, we reasoned that Epha4-deficient mice should also have fasciculation defects. We therefore examined the SGNs from Epha4 À/À embryos at late embryonic ages (Helmbacher et al., 2000; North et al., 2009 ). Compared to their wild-type littermates ( Figures 5A,  5C , 5E, and 5G), Epha4 À/À mice presented fasciculation defects that were remarkably similar to those observed in the Pou3f4 y/À animals ( Figures 5B, 5D , 5F, and 5H; compare to Figure 2 ). Whereas wild-type cochleae showed tight SGN bundles and well-defined mesenchyme bands ( Figures 5A and 5C ), the SGNs in Epha4 À/À cochleae displayed dispersed, poorly fasciculated bundles that aberrantly traversed the mesenchymal space ( Figures 5B and 5D ) and occupied significantly more area at the basal, midmodiolar, and apical regions of the cochlea ( Figure 5I ). Orthogonal reconstructions of these samples illustrate disruptions in the normal interdigitation of the mesenchyme cells and the SGN bundles in the Epha4 À/À mutants ( Figures 5E and 5F). The number of mesenchyme cells in Epha4 À/À cochleae appeared unchanged compared to wild-type, suggesting that the fasciculation defects in the SGNs are not due to a loss of surrounding mesenchyme ( Figures 5G and 5H ). Similar to SGNs from Pou3f4 y/À mice, SGNs from Epha4 À/À mice showed an approximately 4-fold increase in the number of axons that crossed between bundles ( Figure 5J ). Finally, we examined Epha4 À/À cochleae at P7 to determine whether these animals (like Pou3f4 y/À mice) had defects in hair cell innervation and ribbon synapse formation ( Figure S2 ). As a result of early postnatal lethality of this line, we were only able to examine four mutant ears, and thus our conclusions are based on a limited sampling. Compared to controls ( Figures S3A, S3C , and S3D), Epha4 À/À mice showed a nearly 2-fold reduction in the number of ribbon synapses ( Figures S2B, S2E , and S2F), further supporting that SGN fasciculation is important for target innervation. Overall, the fasciculation and synapse defects in Epha4 and Pou3f4 mutants are very similar, consistent with their participation in a common developmental process. To investigate whether EphA4 plays a non-cell-autonomous role during SGN fasciculation, we asked whether exogenous EphA4 extracellular domains (serving as a substitute for mesenchyme) could promote SGN fasciculation in vitro. E12.5 spiral ganglia were cultured for 24 hr (without otic mesenchyme) on a layer of Matrigel infused with either control Fc or EphA4-Fc ( Figures 5K-5M ) to determine the effects on fasciculation. We also examined the effects of preclustering EphA4-Fc to determine whether ''activating'' (preclustered form) or ''blocking'' (unclustered form) ephrin ligands on the SGNs had different effects on fasciculation (Davis et al., 1994) . In the presence of control Fc (preclustered), SGN explants projected mostly single neurites and some rudimentary fascicles ( Figure 5K, see arrowheads) , suggesting that SGNs may have some intrinsic axoaxonal binding capacity. However, explants cultured with preclustered EphA4-Fc showed dramatically enhanced fasciculation, with thick bundles projecting away from the soma ( Figure 5L ) and very few single neurites. Interestingly, EphA4-Fc treatments did not reduce the length of axons (growth cone collapse) compared to controls (data not shown). When we stained these cultures with anti-integrin-a6 antibodies to mark the auditory glia, we found their growth pattern to be almost identical to that of the SGNs, raising the possibility that the glia may also respond to EphA4. However, when the SGNs were eliminated in the presence of high pH culture medium (Mukai et al., 2011) but grown in preclustered EphA4-Fc, the glia persisted but did not bundle ( Figure 5M ), suggesting that SGN fasciculation is not normally a secondary response to aggregating glia. Preclustered EphA4-Fc at 10 nM led to a 4-fold increase in average bundle diameter compared to controls ( Figure 5N ) and doubled the percentage of fascicles greater than 3.5 mm in diameter ( Figure 5O ). Importantly, cultures grown in the presence of unclustered EphA4-Fc showed levels of bundling that were not significantly different from controls (see Figures 5N and 5O ), suggesting that blocking ephrins from recognizing Eph receptors on neighboring axons or glia has little effect on SGN fasciculation. These results demonstrate that EphA4, expressed by mesenchyme cells, may normally activate ephrin ligands expressed by SGNs to promote fasciculation.
Pou3f4 Knockdown In Vitro Causes SGN Fasciculation Defects that Are Rescued by EphA4
To determine whether Pou3f4 and EphA4 are functionally linked, we established an in vitro system to investigate SGN fasciculation using explanted SGNs and otic mesenchyme. At E12.5, the auditory component of the cochleo-vestibular ganglion can be easily isolated and cocultured with pieces of otic mesenchyme; over time these cell populations intercalate, while developing SGNs extend processes ( Figure 6A ; Figure S3 ). In these assays, the SGNs appear to briefly migrate away from the explant and then extend axons (often in clusters with other neurons; see Figure S3 ) at the same time that mesenchyme cells invade. In addition, coculturing the SGNs and mesenchyme in a thick Matrigel layer allows the two cell populations to interact in a semi-three-dimensional gel, mimicking SGN fasciculation in vivo ( Figures S3B and S3C) . To examine the effects of decreased expression of Pou3f4, we used Morpholino antisense oligonucleotides (MOs) to knock down Pou3f4. Figure 6A shows uptake of a control MO-fluorescein isothiocyanate (FITC) conjugate by endocytic vesicles in mesenchyme and neurons. A Pou3f4-specific antisense MO at 20 mM showed a nearly complete knockdown of Pou3f4 ( Figure 6B ). Treatment with the Pou3f4 MO also induced a significant knockdown of Epha4 ( Figure 6C ), confirming a direct effect for Pou3f4 on Epha4 expression. The soma of SGNs maintained in coculture with control MO were typically clustered with one another (Figures 6D and 6E) , and their neurites often formed extensive and straight fascicles that extended through the mesenchyme cells ( Figure 6F; Figure S3) (Simmons et al., 2011) . In contrast, when cultures were treated with the Pou3f4 MO, SGNs failed to form clusters ( Figures 6G and 6H ). Distal processes still extended among the otic mesenchyme cells, but these processes failed to fasciculate and often followed more torturous paths ( Figure 6I ), similar to Pou3f4 y/À cochleae. To quantify these effects, we determined average SGN fascicle diameter for both conditions. In controls, average fascicle diameter was approximately 3.1 mm ( Figure 6K ; individual SGN neurites in culture are small, typically $1 mm in diameter), and 28% of fascicles were classified as large fascicles (larger than or equal to 3.5 mm; Figure 6L ). Fascicles in Pou3f4 MO-treated cultures had a significantly smaller average diameter of 2 mm, and only 8% of the fascicles were classified as large ( Figure 6L ). To determine whether fasciculation loss was a result of downregulating Epha4, we added EphA4-Fc protein to SGN and mesenchyme cultures that had been treated with the Pou3f4 MO. The addition of preclustered EphA4-Fc restored SGN fasciculation ( Figure 6J ) and induced a statistically significant increase in fascicle diameter size, as well as a 12% enhancement of large fascicles ( Figures 6K and 6L ).
Ephrin-B2 Acts as a Cofactor for EphA4 during SGN Fasciculation
We next reasoned that if EphA4 expression by otic mesenchyme cells promotes SGN fasciculation, then at least one ephrin cofactor must be expressed by the SGNs. Thus, an extensive in situ hybridization survey was performed to determine which of the seven known EphA4 ligands (Wilkinson, 2001 ) are expressed by SGNs during mid-to-late gestation ( Figure S4 ; 
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Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculation . For Efna1, Efna5, and Efnb3, mRNA was not detectable at appreciable levels in the cochlea (data not shown). Transcripts for both Efna2 and Efna4 were distributed broadly in the cochlea, including the spiral ganglion, and Efna3 appeared in the SGNs but at a level just slightly above the control probe ( Figure S4 ). In contrast, Efnb2 was detected at high levels in SGNs at E13.5 ( Figure 7A ) and at E15.5, when SGN fasciculation commences ( Figures 7B and 7C ). Ephrin-B2 protein was similarly detected in the SGNs and their axons by immunostaining ( Figure 7D ) and overlapped primarily with neuronal markers (Tuj1; Figures 7E, 7F , and 7H, see arrows), but not with markers of auditory glia (integrin-a6; Figures 7G and 7H , see arrowheads). The complementary expression of ephrin-B2 on SGN axons and EphA4 on adjacent mesenchyme (compare Figure 7D to Figure 4F ) suggested that ephrin-B2 is spatially and temporally positioned to interact with EphA4 during SGN fasciculation. We next predicted that if EphA4 signals through ephrin-B2 in this system, then blocking ephrin-B2 function using unclustered ephrin-B2-Fc would prevent SGN fasciculation in SGN and mesenchyme cocultures, similar to the effects of the Pou3f4 MO. Consistent with this hypothesis, ephrin-B2-Fc led to a nearly 25% decrease in fascicle diameter and a >4-fold decrease in the number of large fascicles, as compared to control (Figures 7I-7L ). We next asked whether the loss of Efnb2 in the SGNs in vivo would lead to fasciculation defects similar to those observed in the Pou3f4 and Epha4 mutants. Because Efnb2 was detectable in regions of the cochlea besides the SGNs, particularly at earlier stages ( Figures 7A, 7B , and 7D), we conditionally removed Efnb2 in the SGNs by crossing Efnb2 loxP mice (Gerety and Anderson, 2002) to mice carrying Ngn-CreERT2 ), a transgene that shows robust reporter activity in the SGNs after tamoxifen delivery ( Figure 7M ). Resulting Efnb2 conditional knockout (cko) mice showed substantially reduced levels of ephrin-B2 protein, particularly in the SGN peripheral axons (Figure S4 ), but not in other regions of the cochlea.
Compared to Cre-positive wild-type littermate controls ( Figures 7N and 7P) , the SGNs from Efnb2 cko cochleae showed both fasciculation defects and axons that aberrantly crossed between fascicles but did not show a loss of mesenchyme ( Figures 7O and 7Q) . Although statistically significant in some cases, these defects were less severe compared to what we observed in the Pou3f4 or Epha4 mutants, probably owing to functional redundancy by other ephrins present or possibly a lack of complete ephrin-B2 elimination. Efnb2 cko cochleae showed a 6% increase in area consumed by axons and maximally a 4-fold increase in the number of axons that crossed between bundles (Figures 7R and 7S ). Because tamoxifen was given at a single dose at E9.5-E10.5, most defects were observed at the base and midmodiolar regions of the cochlea, in accordance with previous studies with Ngn-CreERT2 . Importantly, the Efnb2 cko phenotype was similar to the fasciculation phenotypes observed in both the Pou3f4 and Epha4 mutants lines, suggesting that ephrin-B2 may function as a ligand for EphA4 in this process.
Pou3f4 Associates with Epha4 Regulatory Elements
We next asked whether, in the developing otic mesenchyme, regulatory elements of Epha4 are a direct target of Pou3f4. Pou proteins are known to have a bipartite DNA binding system that includes a POU-specific domain, as well as a homeobox domain (Phillips and Luisi, 2000) . Whereas the recognition sequences of several Pou proteins have been characterized, relatively little is known about mouse Pou3f4. However, one report has demonstrated that Pou3f4 preferentially recognizes the tandem homeobox sequence ATTATTA in the regulation of the dopamine receptor 1A gene D1A (Okazawa et al., 1996) . Therefore, we scanned the entire Epha4 genomic sequence and found four of these sites within introns in the first 70 kilobases (kb) and one approximately 8.5 kb upstream of exon 1 ( Figure 8A ). We then performed chromatin immunoprecipitation (ChIP) using otic mesenchyme and a Pou3f4-specific IgY and assayed the resulting DNAs for these Epha4 regulatory regions using quantitative PCR ( Figure 8B ). In these experiments b-actin, Neurogenin-1, and an Epha4 site that did not contain ATTATTA were used as negative controls; there was no significant association at these sites with the control or Pou3f4-specific IgY. However, all five of the putative Epha4 regulatory regions showed preferential association (with statistical significance) with the Pou3f4-specific IgY, with little to no association with the control IgY ( Figure 8B ). These data suggest that Pou3f4 may directly regulate Epha4 in otic mesenchyme cells in order to initiate EphA4-mediated SGN fasciculation.
DISCUSSION
The results presented in this study reveal a new and intriguing role for otic mesenchyme in the development of cochlear innervation. Moreover, the identification of additional auditory defects arising from the absence of Pou3f4 provides insights into the underlying basis for the deafness that occurs in both human and murine mutants. Previous reports have demonstrated a significant decrease in endocochlear potential that is almost certainly a major component of the auditory dysfunction, but the demonstration of a 30% decrease in the number of ribbon synapses may indicate a significant loss in acuity. Although this hypothesis cannot be tested without a mouse model in which endocochlear potential is preserved, it would need to be considered in terms of developing any potential therapeutic interventions.
The results presented here identify a molecular signaling pathway in which Pou3f4 expression in otic mesenchyme cells directly activates Epha4, leading to the expression of EphA4 on the surface of these cells ( Figure 8C ). The presence of EphA4 provides a cue that acts, along with the spatial distribution of (R and S) Histograms illustrating axon fasciculation defects (R) and the number of times per 500 mm that individual processes crossed between fascicles (S). Percentages indicate the position along the length of the cochlea with respect to the distance from the base. *p % 0.05; **p % 0.01. 
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Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculation otic mesenchyme, to promote fasciculation of SGNs via binding to ephrin-B2 on their surfaces. Furthermore, these data predict that EphA4 activates ephrin-B2 to generate a reverse signaling response to segregate the SGNs and mesenchyme in a manner classically documented in zebrafish animal cap assays (Mellitzer et al., 1999) . However, the mechanism(s) by which ephrin-B2 promotes fasciculation among the SGN axons remains unclear. Ephrin-B2 reverse signaling may induce filopodial collapse (Cowan and Henkemeyer, 2001 ) by the SGN growth cones, which, by default, may lead them to preferentially associate with neighboring axons. Or ephrin-B2 reverse signaling may promote SGN interaxonal adhesion by signaling to other cell-surface factors known to regulate fasciculation, such as IgCAMs (Lin et al., 1994) and/or integrins (Baum and Garriga, 1997) .
These results reveal the molecular basis for the organizing effects of otic mesenchyme and show a paracrine mode of action for Pou3f4 in axon guidance. Interestingly, Pou4F2 (Brn3b) is known to regulate axon pathfinding and fasciculation in retinal ganglion cells through an autocrine signaling pathway (Pan et al., 2008) , and in Drosophila, deletion of the Pou3f4 ortholog ventral veins lacking (vvl) leads to defects in fasciculation and steering of axons in the fly brain, although much of these defects may be secondary to effects on neuronal specification (Meier et al., 2006) . In addition, although this demonstrates a role for Eph-ephrin signaling in the initial development of the peripheral auditory system, elegant work by Huffman and Cramer (2007) has already demonstrated a role for EphA4 in hearing and central auditory plasticity (Hsieh et al., 2007; Huffman and Cramer, 2007) . These authors showed that, after surgically removing the cochlea (and peripheral input to the brain), the expression of Epha4 was critical for target selection during remodeling (Hsieh et al., 2007; Miko et al., 2008) . The functions of ephrinEph receptor interactions probably go well beyond those presented here and in previous publications. As shown in Figure S4 and in previous reports, several other ephrins and Ephs are expressed in the cochlea (Bianchi and Gale, 1998; Zhou et al., 2011) and may serve a variety of additional functions. This may also indicate why EphA4-Fc was only able to partially rescue the fasciculation defects in the absence of Pou3f4 (Figure 6 ). In particular, axon-axon interactions by Ephs and ephrins may also play a role in SGN radial bundle formation, similar to the coordinated actions of motor and sensory axons, as has been shown recently (Gallarda et al., 2008; Wang et al., 2011) . Indeed, when cultured in the absence of mesenchyme, SGNs have some intrinsic capacity to fasciculate. Inhibiting ephrins expressed on SGNs with unclustered EphA4-Fc did not diminish fasciculation compared to controls (Figure 5 ), but a more complete characterization of other Eph-ephrin interactions would be required to eliminate this possibility.
The innervation patterns of the mammalian auditory system are remarkably complex, containing multiple fiber and bundle types (reviewed in Appler and Goodrich, 2011) . Despite a wealth of descriptive and functional studies beginning as early as the late 1800s, the specific functions of different fiber tracts and neuronal cell types are only now being elucidated. Mutations in Pou3f4, Epha4, or Efnb2 lead to defects in the formation of radial fiber bundles, but the functions of these bundles are unknown. Considering their regular alignment along the tonotopic axis of the cochlea, it has been suggested that each bundle may contain fibers tuned to a specific frequency and that radial bundle formation may thus play an important role in coordinating frequency matching between SGNs and auditory hair cells (Rubel and Fritzsch, 2002) . If this is the case, then defects in radial bundle formation, such as those reported in this study, could lead to significant tonotopic defects in the cochlea and possibly higher CNS auditory nuclei. This conclusion is supported by the significant functional and morphological defects in the auditory systems of Epha4 and Efnb2 mutant mice (Miko et al., 2008) , with auditory brainstem response waveform signatures suggesting defects both peripherally and centrally. Unfortunately, the direct roles of EphA4 and ephrin-B2 in the formation of tonotopic organization in the auditory brainstem make it impossible to discern the specific effects of defects in radial bundle formation without generating inner-ear-specific mutants.
The increased number of crossing fibers and the decrease in ribbon synapses observed in Pou3f4/Epha4/Efnb2 mutants indicate that fasciculation signals arising from surrounding otic mesenchyme clearly act to prevent routing errors within the mesenchymal space by driving SGN fibers onto existing radial bundles. Previous studies indicated that otic mesenchyme cells express EphA4 protein (Pickles et al., 2002; van Heumen et al., 2000) and that EphA4 prevented outgrowth of mature SGNs in vitro (Brors et al., 2003) . However, the results presented here demonstrate that for immature SGNs, rather than inhibiting axon outgrowth, EphA4/ephrin-B2 interactions act to form a barrier that promotes SGN fasciculation without affecting outgrowth. Overall, the factors that guide SGN axons during their pathfinding remain unknown. Neurotrophin signaling through TrkB and TrkC, although critical for growth and maintenance of SGNs, is not required for the directed outgrowth of SGNs (Fekete and Campero, 2007; Fritzsch et al., 2005) . Additional studies will clearly be required to identify the neurotropic factors for SGNs.
EXPERIMENTAL PROCEDURES Animal Care and Tissue Preparation
All animals used in this study were maintained in accordance with the National Institutes of Health (NIH) Care and Use Committee. Timed pregnant CD1 mice (Charles River Laboratories) were used for protein expression studies and neuron and mesenchyme explant cultures. Pou3f4 mutant mice, in which the coding region was replaced with Cre recombinase, were maintained on a mixed background. This line phenocopies a previously published Pou3f4 knockout mouse (Phippard et al., 1999) . Because Pou3f4 is on the X chromosome, only males were used in this study in order to avoid variability arising from X inactivation. In order to generate hemizygous males, we crossed Pou3f4 +/À females to wild-type CD1 males. To generate conditional Efnb2 knockout animals (Efnb2 cko), we bred C57/BL6 Efnb2 flox/flox mice (Gerety and Anderson, 2002) with mice carrying the Neurogenin (Ngn)-CreERT2 transgene on a mixed CD1 background. Ngn1
CreERT2 ;
Efnb2
flox/+ mice were crossed, and pregnant dams were gavaged with a single dose of tamoxifen (Sigma; solubilized in flax and sunflower seed oil; 0.5 mg/ 40 g body weight) at 9.5-10.5 days gestation. Through the use of this strategy, we found Cre reporter activity in 95%-100% of SGNs at the cochlear base (R26R-YFP; Jackson Laboratory; Figure 7 ).
Immunostaining and In Situ Hybridization
For whole-mount immunostaining of the SGNs, we isolated cochleae from the vestibular components, bony capsule, and associated stria. Following permeabilization with 0.5% Triton X-100 and blocking with 10% serum, the cochleae were incubated overnight at 4 C in primary antibodies and then rinsed extensively. Fluorescent secondary antibodies (Invitrogen, 1:1,000)
were applied for 1 hr at room temperature. For culture explants and cryoprotected tissue sections, we performed antibody staining as described previously (Driver et al., 2008) . Confocal z stack images were obtained using an LSM-510 (Zeiss), projected using NIH-ImageJ, and then further processed using Adobe Photoshop. In situ hybridization was performed as described (Raft et al., 2007) . For all templates, sense controls were generated in parallel. Tissue processing, sectioning, hybridization, and detection were performed as previously described (Raft et al., 2007) .
Neuron and Mesenchyme Culture Experiments CD1 embryos were prepared for culture experiments as described previously (Montcouquiol et al., 2003) . Culture medium included Dulbecco's modified Eagle's medium, 10% fetal bovine serum, 0.2% N2, and 0.001% ciprofloxacin.
In pilot experiments, we determined that the spiral ganglion persisted in culture up to 5 days without additional neurotrophins only if the glia were not removed. For the 24 hr Matrigel outgrowth assays, MatTek dishes were coated (24 hr at 37 C) with 10% Matrigel mixed with either human IgG-Fc (Jackson Immunoresearch) or EphA4-Fc (R&D Systems). To precluster the Fc fusion proteins for some experiments, we combined each Fc protein with mouseanti-human Fc (Jackson Immunoresearch) for 1 hr at a 1:10 molar ratio. For each experiment, the spiral ganglion was removed at E12.5 and placed onto a precoated dish with normal culture medium and permitted to grow for 24 hr. For neuron and mesenchyme coculture experiments, a spiral ganglion and an equivalent-sized portion of otic mesenchyme were removed from the cochlea at E12.5 and transferred to Matrigel-coated MatTek dishes (5% for 1 hr at 37 C), containing solutions of either standard control MO or a Pou3f4-specific MO (GATCCTCTACTAGTTATAATGTGGC). Neuron and mesenchyme explants were plated approximately 1 mm from each other before receiving Endo-Porter (0.6% final; Gene Tools) to facilitate delivery of the MOs. After 2 days at 37 C, the MO and Endo-Porter-containing medium was replaced with normal culture medium and grown an additional 3 days. For some experiments, soluble preclustered human IgG-Fc or EphA4-Fc was added to cultures following 2 days Morpholino exposure. Both IgG-Fc and EphA4-Fc were used at 10 nM based on a previous report (Brors et al., 2003) . For culture experiments comparing Fc versus ephrin-B2-Fc (R&D Systems), we did not perform preclustering.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Jhingory et al., 2010) but with minor modification. E15.5 cochleae were isolated in chilled PBS and then fixed for 20 min using 4% paraformaldehyde. The Agarose ChIP Kit (Pierce) was used for subsequent DNA digestion and precipitation. Approximately 8 mg of chicken anti-Pou3f4 or chicken IgY (negative control) and PrecipHen beads (Aves Labs) was used for IP. With resulting DNAs, we performed qPCR using SYBR Green. For each primer set, a standard curve was generated using mouse genomic DNA; control and experimental C t values were compared to this standard curve for quantification. The data here represent at least two independent ChIPs and three qPCR analyses for each primer set. Please see Supplemental Experimental Procedures for lists of the antibodies, in situ hybridization probes, qPCR primers, quantification methods used in the study, and a description of the microarray that identified Epha4.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j. neuron.2011.10.029.
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